160 related articles for article (PubMed ID: 28427228)
1. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway.
Li ZH; Xiong QY; Xu L; Duan P; Yang QO; Zhou P; Tu JH
Oncotarget; 2017 May; 8(20):32566-32575. PubMed ID: 28427228
[TBL] [Abstract][Full Text] [Related]
2. miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1.
Zhao Y; Yang F; Li W; Xu C; Li L; Chen L; Liu Y; Sun P
Tumour Biol; 2017 Feb; 39(2):1010428317692264. PubMed ID: 28222663
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
4. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
[TBL] [Abstract][Full Text] [Related]
5. Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.
Lü J; Zhao Q; Guo Y; Li D; Xie H; Liu C; Hu X; Liu S; Hou Z; Wei X; Zheng D; Pestell RG; Yu Z
J Exp Clin Cancer Res; 2023 Apr; 42(1):93. PubMed ID: 37081505
[TBL] [Abstract][Full Text] [Related]
6. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
7. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
Chen R; Zhang L
Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771
[TBL] [Abstract][Full Text] [Related]
8. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
[TBL] [Abstract][Full Text] [Related]
9. MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1.
Pei YF; Lei Y; Liu XQ
Biochim Biophys Acta; 2016 Nov; 1862(11):2177-2185. PubMed ID: 27555295
[TBL] [Abstract][Full Text] [Related]
10. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
12. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
13. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
Lin L; Liu D; Liang H; Xue L; Su C; Liu M
Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
[TBL] [Abstract][Full Text] [Related]
14. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
16. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
17. CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis.
Zhao B; Song X; Guan H
Life Sci; 2020 Mar; 244():117179. PubMed ID: 31863774
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
Ma J; Li T; Yuan H; Han X; Shui S; Guo D; Yan L
J Cell Biochem; 2018 Mar; 119(3):2617-2626. PubMed ID: 29023945
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin.
Hong H; Yu H; Yuan J; Guo C; Cao H; Li W; Xiao C
Med Sci Monit; 2016 Jun; 22():1946-52. PubMed ID: 27276064
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
Jiang H; Li X; Wang W; Dong H
BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
